Hepatitis B

Coverage of the 2017 AASLD Liver Meeting

HIVandHepatitis.com coverage of the 2017 Liver Meeting, the annual conference of the American Association for the Study of Liver Diseases, AASLD), October 20-24, 2017, in Washington, DC.

Hepatitis C

• More Work and Lower Drug Prices Needed to Eliminate Hepatitis C Worldwide
• Sofosbuvir/Ledipasvir for 8 Weeks Cures Acute HCV in People with HIV
• Curing Hepatitis C Leads to Improved Quality of Life
• Mavyret Shows High Cure Rates for HCV Genotype 3 and Cirrhosis
• Curing Hepatitis C with DAAs Reduces Liver Cancer Risk
• HCV Infections Are Rising Among HIV+ Gay Men In San Diego
• Model Shows Hepatitis C Treatment is Cost-Effective in Japan
• Hepatitis C Testing Linked to Reduced Opioid Use

Hepatitis B

• TAF for Hepatitis B Improves Kidney Function and Bone Loss
• REP 2139 Combination Therapy Leads to Functional Control of Hepatitis B Virus
• Immune Modulator Inarigivir Looks Promising for People with Hepatitis B
• RNA Interference Therapy Lowers Viral Biomarker in People with Hepatitis B
• Treatment that Interferes with Viral Assembly Shows Promise for Hepatitis B
• Daily Aspirin Linked to Lower Liver Cancer Risk for Hepatitis B Patients

Fatty Liver Disease

• Experimental NASH Therapy Improves Liver Fat and Fibrosis

• Women with Fatty Liver Disease at Higher Risk for Heart Disease

Liver Cancer

• Nivolumab Improves Outcomes in Liver Cancer Study
• Daily Aspirin Linked to Lower Liver Cancer Risk for Hepatitis B Patients
• Curing Hepatitis C with DAAs Reduces Liver Cancer Risk

11/30/17